Evidence map›Paper›PMID 28121479›Full record

ArticleChannels (Austin, Tex.)2017

Cisplatin activates volume sensitive LRRC8 channel mediated currents in Xenopus oocytes.

Antonella Gradogna, Héctor Gaitán-Peñas, Anna Boccaccio, Raúl Estévez, Michael Pusch

Open access · goldAbstract read
In one paragraph

Article in Channels (Austin, Tex.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Ion Channel Involvement in Tumor Drug Resistance.Journal of personalized medicine · 2022
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Antonella Gradognaa Institute of Biophysics, National Research Council , Genova , Italy.
Héctor Gaitán-Peñasb Departament de Ciències Fisiològiques II , Unitat de Fisiologia, IDIBELL-Universitat de Barcelona, L'Hospitalet de Llobregat , Barcelona , Spain.
Anna Boccaccioa Institute of Biophysics, National Research Council , Genova , Italy.
Raúl Estévezb Departament de Ciències Fisiològiques II , Unitat de Fisiologia, IDIBELL-Universitat de Barcelona, L'Hospitalet de Llobregat , Barcelona , Spain.
Michael Puscha Institute of Biophysics, National Research Council , Genova , Italy.ORCID http://orcid.org/0000-0002-8644-8847
National Research Council · ITInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LRRC8 proteins have been shown to underlie the ubiquitous volume regulated anion channel (VRAC). VRAC channels are composed of the LRRC8A subunit and at least one among the LRRC8B-E subunits. In addition to their role in volume regulation, LRRC8 proteins have been implicated in the uptake of chemotherapeutic agents. We had found that LRRC8 channels can be conveniently expressed in Xenopus oocytes, a system without endogenous VRAC activity. The fusion with fluorescent proteins yielded constitutive activity for A/C, A/D and A/E heteromers. Here we tested the effect of the anticancer drug cisplatin on LRRC8A-VFP/8E-mCherry and LRRC8A-VFP/8D-mCherry co-expressing oocytes. Incubation with cisplatin dramatically activated currents for both subunit combinations, confirming that VRAC channels provide an uptake pathway for cisplatin and that intracellular cisplatin accumulation strongly activates the channels. Thus, specific activators of LRRC8 proteins might be useful tools to counteract chemotherapeutic drug resistance.

Indexed as

AnimalsCisplatinElectrophysiological PhenomenaIon ChannelsOocytesXenopusCisplatinIon Channelsanionchloride channelcisplatindrug resistanceoocytevolume regulationVRAC

Identifiers

PMID28121479
PMCPMC5463888
OpenAlexW2581551259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.